14 Sep 2010 16:19
ο»Ώ
Β
Β
Β
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
Β
|
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Ark Therapeutics Group Plc |
Β
|
2 Reason for the notification (please tick the appropriate box or boxes): |
||
|
Β An acquisition or disposal of voting rights |
YES |
|
|
Β An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|
|
Β An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|
|
Β An event changing the breakdown of voting rights |
|
|
|
Β Other (please specify): |
|
|
Β
|
3. Full name of person(s) subject to the notification obligation: Β |
J O Hambro Capital Management Group Limited |
|
4. Full name of shareholder(s) (if different from 3.): Β |
|
|
5. Date of the transaction and date on which the threshold is crossed or reached: Β |
9 September 2010 |
|
6. Date on which issuer notified: Β |
13 September 2010 Β |
|
7. Threshold(s) that is/are crossed or reached: Β |
Below 10% |
Β
|
8. Notified details: |
|||||||
|
A: Voting rights attached to shares Β |
|||||||
|
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
|||||
|
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
|||
|
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||
|
Ordinary |
21,676,602 |
21,676,602 |
20,659,450 |
20,659,450 |
|
9.87% |
|
|
Sedol: 3425172 |
|||||||
Β
|
B: Qualifying Financial Instruments |
||||
|
Resulting situation after the triggering transaction Β |
||||
|
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period |
Number of voting rights that may be acquired if the instrument is exercised/ converted. Β |
% of voting rights |
|
|
|
|
|
|
Β
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||
|
Resulting situation after the triggering transaction Β |
||||||
|
Type of financial instrument |
Exercise price |
Expiration date |
Exercise/ Conversion period |
Number of voting rights instrument refers to |
% of voting rights Β |
|
|
|
|
|
|
|
Nominal |
Delta Β |
|
|
|
|||||
Β
|
Total (A+B+C) Β |
|
|
Number of voting rights |
Percentage of voting rights |
|
20,659,450 |
9.87% |
Β
|
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
|
Not applicable |
Β
|
Proxy Voting: Β |
|
|
10. Name of the proxy holder: Β |
- |
|
11. Number of voting rights proxy holder will cease to hold: Β |
- |
|
12. Date on which proxy holder will cease to hold voting rights: Β |
- |
Β
|
13. Additional information: |
|
|
14. Contact name: Β |
Mark Purnell |
|
15. Contact telephone number: Β |
020 7747 8952 |
Β
Follow the stocks